Table 2.

Serum concentrations of the studied parameters in healthy controls (group I), ischemic heart disease (group II), type 2 DM who did not perform CABG (group III), and type 2 DM who performed CABG (group IV). Values are median (with the 25th and 75th centiles-quartiles).

Groups/parameters	Group I	Group II	Group III	Group IV
n	12	15	15	15
MDA (nmol/mL)	1 (0-1)	4 (1–4) (a)	9 (7–13) (a, b)	10 (9–12) (a, b)
hsCRP (mg/L)	0.4 (0-1)	3 (2–4) (a)	9 (8–10) (a, b)	10 (9–11) (a, b)
ET-1 (pg/mL)	3 (1–3)	2 (2–4)	10 (9–18) (a, b)	10 (9–12) (a, b)
P-selectin (ng/mL)	67 (60–110)	52 (14–137)	95 (48–212) (a)	98 (84–155)
ICAM-1 (ng/mL)	140 (107–194)	236 (153–284) (a)	367 (246–449) (a, b)	473 (429–512) (a, b)
VCAM-1 (ng/mL)	608 (388–848)	625 (247–944)	1167 (987–1284) (a, b)	977 (840–1244) (a, b)

(a, b, c) Significant difference from healthy controls, IHD group, type 2 DM group who did not perform CABG, respectively, at P ≤ .05.